A continuous key challenge for health-related research is the translation of basic research into clinical practice. Thus, efficient support structures are needed to promote the progress of research findings into clinical application. The fundamental coordinated approaches for bridging the two ends – from bench to bedside – have been proven and are still being further improved as best practice models in the Interdisciplinary Centre for Clinical Research (IZKF) at the Medical Faculty of the University of Münster.
The IZKF is a collaborative funding centre for disease-oriented research, established in the mid-90s at the University of Münster by the first structural development programme of the German Federal Government in university medicine. Today, the IZKF is consolidated in the budget of the Medical Faculty and offers various funding instruments to support high-level research with clinical perspective. This includes 3-year research grants, SEED funding to help young clinician scientists to establish their own research group and ClinicSTART projects to initiate small investigator-driven clinical trials. Furthermore, the IZKF initiates and supports core facility activities, which has helped the Medical Faculty to install important and well used service platforms, e.g. in multimodal imaging or genomics.
The overall goal of the IZKF Münster is to foster the translation of basic research findings into clinical practice, thereby facilitating the integration between different disciplines of basic and clinical science and enhancing internationally recognised top-level research. It offers research grants in all defined profile research areas of the Medical Faculty Münster, i.e. (a) inflammation and infection, (b) vascular diseases, (c) nervous system diseases and (d) cell differentiation, regeneration and neoplasia. With this strategy, it helps to promote the development of new joint interdisciplinary research activities.
This Highlight Issue of Biological Chemistry is published on the occasion of IZKF Münster’s 25th anniversary. It includes review articles of current and former members of the IZKF covering a wide range of topics, from oncology to dermatology, or infection research to immunology, representing the broad spectrum and the interdisciplinary nature of scientific research within the IZKF. All authors have received or receive funding by the IZKF and it is only fair to say, that the IZKF support was and still is a vital and very successful instrument to drive forward individual research careers and to develop individual research profiles.
Acknowledgements
We gratefully acknowledge all authors who contributed to this issue for their scholarly contributions.
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: None declared.
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
© 2021 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Highlight: Molecular Determinants of Health and Disease - 25th Anniversary of the InterdisciplinaryCenter Clinical Research Münster
- Molecular determinants of health and disease
- Role of the gut microbiota in airway immunity and host defense against respiratory infections
- Dynamic phospho-modification of viral proteins as a crucial regulatory layer of influenza A virus replication and innate immune responses
- Molecular mechanisms of vasculopathy and coagulopathy in COVID-19
- Astrocytic potassium and calcium channels as integrators of the inflammatory and ischemic CNS microenvironment
- Epitranscriptomic modifications in acute myeloid leukemia: m6A and 2′-O-methylation as targets for novel therapeutic strategies
- Molecular determinants of therapy response of venetoclax-based combinations in acute myeloid leukemia
- Pseudomonas aeruginosa and Staphylococcus aureus virulence factors as biomarkers of infection
- Controllers of cutaneous regulatory T cells: ultraviolet radiation and the skin microbiome
- The paracaspase MALT1 in psoriasis
- The cAMP responsive element modulator (CREM) is a regulator of CD4+ T cell function
- Quantifying salt sensitivity
- Life sciences and mass spectrometry: some personal reflections
Articles in the same Issue
- Frontmatter
- Highlight: Molecular Determinants of Health and Disease - 25th Anniversary of the InterdisciplinaryCenter Clinical Research Münster
- Molecular determinants of health and disease
- Role of the gut microbiota in airway immunity and host defense against respiratory infections
- Dynamic phospho-modification of viral proteins as a crucial regulatory layer of influenza A virus replication and innate immune responses
- Molecular mechanisms of vasculopathy and coagulopathy in COVID-19
- Astrocytic potassium and calcium channels as integrators of the inflammatory and ischemic CNS microenvironment
- Epitranscriptomic modifications in acute myeloid leukemia: m6A and 2′-O-methylation as targets for novel therapeutic strategies
- Molecular determinants of therapy response of venetoclax-based combinations in acute myeloid leukemia
- Pseudomonas aeruginosa and Staphylococcus aureus virulence factors as biomarkers of infection
- Controllers of cutaneous regulatory T cells: ultraviolet radiation and the skin microbiome
- The paracaspase MALT1 in psoriasis
- The cAMP responsive element modulator (CREM) is a regulator of CD4+ T cell function
- Quantifying salt sensitivity
- Life sciences and mass spectrometry: some personal reflections